Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
Lo TH, Abadir E, Gasiorowski RE, Kabani K, Ramesh M, Orellana D, Fromm PD, Kupresanin F, Newman E, Cunningham I, Hart DNJ, Silveira PA, Clark GJ.
Lo TH, et al. Among authors: ramesh m.
PLoS One. 2019 May 10;14(5):e0216368. doi: 10.1371/journal.pone.0216368. eCollection 2019.
PLoS One. 2019.
PMID: 31075107
Free PMC article.